skip to Main Content

EUROQOL | News

Interviewer Administered Proxy 1 versions of the EQ-5D now available in 30 languages

EuroQol is pleased to announce that its Version Management Committee has recently approved 30 language versions of the Interviewer Administered (IA) Proxy 1 EQ-5D variant. The Proxy 1 IA version is available in 28 languages…

Read more...

New version of the EQ-5D-Y User Guide now available for download!

The EuroQol Office is pleased to announce that a new version of the EQ-5D-Y User Guide is available for download. The guide provides users with information on how to analyse, score and present results from…

Read more...

New update of official guide to the methods of economic evaluation for France recommends use of EQ-5D-5L to derive a utility score

The French National Authority for Health (Haute Autorité de Santé or HAS) has recently published its first update of its official methodological guide for economic evaluation (Choix méthodologiques pour l'évaluation économique à la HAS). One…

Read more...

The 10th Joint Call for Proposals by the EQ Working Groups is now open!

The EuroQol Research Foundation is inviting applications for funding by its competitive research funding programs. Through this program, the Foundation aims to serve the public interest by supporting scientific research and development of instruments which…

Read more...

Comprehensive guide on how to analyse EQ-5D data is published

We welcome the publication of the detailed guide by Prof. Nancy Devlin, Prof. David Parkin and Dr Bas Janssen on how to analyse and report data produced by the EQ-5D. The authors have explained methods…

Read more...

EuroQol launches a new whiteboard animation, ‘Translating patient reported outcome measures for use around the world: the example of EQ-5D’

EuroQol is proud to announce the launch of a new whiteboard animation 'Translating patient reported outcome measures for use around the world: the example of EQ-5D’ , providing a step-by-step overview of how to translate…

Read more...

Study team appointed for the new UK EQ-5D-5L valuation study

The research team for the new EQ-5D-5L valuation study for the United Kingdom has been finalised. This team will bring significant experience and expertise to the valuation study. They were carefully selected by the project’s…

Read more...

EQ-5D is the most commonly cited multi-attribute utility instrument in review of national pharmacoeconomic guidelines

A review identifying which multi-attribute utility instruments (MAUIs) are recommended for use in official national pharmacoeconomic (PE) guidelines has been published in the European Journal of Health Economics. The study reviewed PE guidelines where health…

Read more...

First EuroQol approved sign language version of the EQ-5D-5L is now available

EuroQol is pleased to announce the release of the British Sign Language (BSL) version of the EQ-5D-5L instrument. This is the first sign language version that has been approved by EuroQol. The EuroQol Board and…

Read more...

The 2nd EuroQol Asia Academy Meeting is postponed until 2021

In light of current situation of the Covid-19 in around the globe, where some countries (e.g., Singapore) are having second wave and in some others (e.g., Indonesia, Malaysia, India) the measures being implemented by the…

Read more...
Back To Top
×Close search
Search